PEGylated liposomes as an emerging therapeutic platform for oral nanomedicine in cancer therapy: In vitro and in vivo assessment
A Singh, YR Neupane, S Shafi, B Mangla… - Journal of molecular …, 2020 - Elsevier
In the rapidly expanding field of nanomedicine, liposomes have been considered as the
most successful drug carrier having various clinically approved products. However, their
delivery via oral route has been a persistent challenge due to harsh environment of the
gastrointestinal tract. Herein, we explored the potential of PEGylation onto liposomes as an
effective strategy to protect them from harsh gastric environment and as a successful drug
delivery carrier for oral drug delivery. Conventional and PEGylated liposomes loaded with …
most successful drug carrier having various clinically approved products. However, their
delivery via oral route has been a persistent challenge due to harsh environment of the
gastrointestinal tract. Herein, we explored the potential of PEGylation onto liposomes as an
effective strategy to protect them from harsh gastric environment and as a successful drug
delivery carrier for oral drug delivery. Conventional and PEGylated liposomes loaded with …
以上显示的是最相近的搜索结果。 查看全部搜索结果